|
Extensive work with sponsors gives John Vogel
a "bird’s eye" view of their needs and expectations and
prepares him to consult on strategic issues for service providers,
CROs, SMOs, AROs and investigators. To ensure there is no conflict
of interest, John Vogel does not promote any particular service
provider or service, and he does not identify marketing contacts
within the pharmaceutical industry.
"Dr.
Vogel is providing a valuable service to the drug development
industry. He identifies and brings to the table the tough issues
which need to be addressed to improve outsourcing between the
pharmaceutical industry and service providers. He also knows
what the industry is looking for and has played an important
role in how we present our capabilities to both our current
and future clients."
Arthur
R. Kamm, Ph.D.
President and CEO
A.R. Kamm Associates, Inc.
"Dr.
Vogel's extensive understanding of the clinical trials industry
enabled him to critique our service offerings and positioning
to assure we were addressing the needs of clients and effectively
communicating those service offerings to clients."
Michael K. Lester
President
and CEO
Radiant
Research, Inc.
A typical consulting day
with a service provider begins with the presentation "A View
of the Status and Future of Global Pharmaceutical Outsourcing".
The talk is targeted to management and technical staff and covers
the following areas:
- Changes
in sponsor attitudes towards outsourcing
- Changes
in the pharmaceutical services industry
- Changes
in the way that sponsors are outsourcing
- The
market for pharmaceutical services
- Critical
success factors
- Tools
for managing the sponsor-provider relationship
- Trends
and issues for the future
The seminar usually runs
about 2 ½-hours. The remainder of the consulting day is spent meeting
with staff, discussing specific issues identified by the service
provider, reviewing and critiquing the provider’s marketing plan
and reviewing its operations.
The benefits to pharmaceutical
service providers include:
- Understanding the changing
role of outsourcing in drug development
- Gaining insights into
new challenges facing the industry
- Realizing what sponsors
expect from service providers
- Learning useful techniques
for enhancing relationships with sponsors
- Exploring the future role
of the provider in pharmaceutical outsourcing
- Receiving practical suggestions
on how to improve the service provider’s marketing strategy
Dr. Vogel can also provide
customized in-house training on working effectively with sponsors.
This one-day workshop includes lecture, role-plays, problem solving
and discussion.
Clients
have included:
- ARC
- Ammsys Research
- BRI
- Brecco Research
- Clinical Studies
Ltd.
- ClinPath
- ClinTrials Research
- Covance
- CroMedica
- Duke University
- Harvard University
- Hill Top Research
|
- IBAH
- IBRD-Rostrum
- Innovex
- InSite
- A.R. Kamm Assoc.
- Kern McNeill Int’l.
- Kendle
- Harris
- MedCath
- MedSites
- MIMC
- NCGS & Associates
|
- PACT
- Paragon Biomedical
- Parexel
- PPD-Pharmaco
- Phoenix Int’l.
- Quintiles
- Radiant Research
- RRI
- SciRex
- Univ. of Pittsburgh
- Univ. of Rochester
- West Pharmaceutical
Services
|
[ About
JRVogel ][ Pharmaceutical companies ] [ In-house
training ]
[ CROs, SMOS, AROs & investigators ] [Find
Qualified Providers ]
[ Pharmaceutical outsourcing forum ] [
Recommended links ] [ Contact us ] [ Home
]
John
R. Vogel Associates, Inc.
328 Pualoa Nani Place / Kihei, HI 96753
Phone: (808) 875-6063 / Fax: (808) 875-0913
Email: mail@jrvogel.com
|
